By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.

By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.
复制标题

hsa-miR-526b 通过下调 Ku80 抑制非小细胞肺癌

DOI:
10.18632/oncotarget.2808
复制
发表时间:
2015-01-30
期刊:
影响因子:
--
通讯作者:
Wei S
Wei S
中科院分区:
其他
文献类型:
--
作者:
Zhang ZY;Fu SL;Xu SQ;Zhou X;Liu XS;Xu YJ;Zhao JP;Wei S

文献摘要

参考文献

相似文献

Ku 80参与DNA双链断裂(DSB)修复。Ku 80在肺癌组织中过表达,但其分子机制尚未研究。我们发现miRNA hsa-miR-526 b与Ku 80 mRNA的3′-UTR结合,从而降低了Ku 80在NSCLC细胞中的表达。与相应的非肿瘤组织相比,Hsa-miR-526 b在NSCLC组织中下调,其表达与Ku 80上调呈负相关。Ku 80过表达和hsa-miR-526 b下调与NSCLC患者的不良临床结局相关。Hsa-miR-526 b抑制NSCLC细胞增殖、克隆形成,并诱导细胞周期停滞和凋亡。Hsa-miR-526 b抑制异种移植物和原位肺肿瘤生长。此外,Ku 80在NSCLC细胞中的敲低抑制了体外和体内的肿瘤特性,类似于hsa-miR-526 b过表达。一致的是,Ku 80恢复在体外和体内部分逆转了hsa-miR-526 b诱导的NSCLC细胞细胞周期停滞和细胞凋亡。此外,hsa-miR-526 b过表达或Ku 80敲低可增加p53和p21 CIP 1/WAF 1的表达。这些发现表明hsa-miR-526 b是癌症治疗的潜在靶点。
Ku80 is involved in DNA double-strand breaks (DSBs) repair. Ku80 is overexpressed in lung cancer tissues, yet, molecular mechanisms have not been examined. We identified that miRNA, hsa-miR-526b, is bound to the 3′-UTR of Ku80 mRNA, thus decreasing Ku80 expression in NSCLC cells. Hsa-miR-526b was downregulated in NSCLC tissues compared with corresponding non-tumorous tissues, and its expression was inversely correlated with Ku80 upregulation. Overexpression of Ku80 and downregulation of hsa-miR-526b were associated with poor clinical outcomes of NSCLC patients. Hsa-miR-526b suppressed NSCLC cell proliferation, clonogenicity, and induced cell cycle arrest and apoptosis. Hsa-miR-526b inhibited xenografts and orthotopic lung tumor growth. Further, Ku80 knockdown in NSCLC cells suppressed tumor properties in vitro and in vivo similar to hsa-miR-526b overexpression. In agreement, Ku80 restoration partially reversed cell cycle arrest and apoptosis induced by hsa-miR-526b in NSCLC cells in vitro and in vivo. In addition, hsa-miR-526b overexpression or Ku80 knockdown increased p53 and p21CIP1/WAF1 expression. These findings reveal that hsa-miR-526b is a potential target in cancer therapy.
DOI: 10.1056/nejmoa040938
发表时间: 2004-05-20
影响因子: 158.5
作者:
Lynch, TJ;Bell, DW;Haber, DA
通讯作者: Haber, DA
DOI: 10.1073/pnas.022649699
发表时间: 2002-01-22
影响因子: 11.1
作者:
Li, G;Nelsen, C;Hendrickson, EA
通讯作者: Hendrickson, EA
DOI: 10.1371/journal.pone.0090008
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Fan QH;Yu R;Huang WX;Cui XX;Luo BH;Zhang LY
通讯作者: Zhang LY
DOI: 10.3816/clc.2001.n.006
发表时间: 2001-02-01
影响因子: 3.6
作者:
Korrapati, V;Gaffney, M;Mott, F E
通讯作者: Mott, F E
DOI: 10.3892/ol.2013.1375
发表时间: 2013-08
期刊: Oncology letters
影响因子: 2.9
作者:
Nian W;Ao X;Wu Y;Huang Y;Shao J;Wang Y;Chen Z;Chen F;Wang D
通讯作者: Wang D